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INTRODUCTION 
A wise man once said; “Life is short, and the Art long; 
the occasion fleeting; experience fallacious, and 
judgment difficult. The physician must not only be 
prepared to do what is right himself but also to make 
patients, the attendants, and the external cooperate”. This 
man lived 400 B.C. and his name was Hippocrates1. 
Good clinicians have always organized some kind of 
systemic review of their daily work, recording and 
assessing the accuracy, of their diagnosis and the 
outcome of their treatment. We have learnt to call this 
kind of activity audit 2.  
Medical Audit may be defined simply as looking at what 
we are doing with the aim of making improvements in 
patient care and use of resources 3. It is the systematic, 
critical analysis of the quality of medical care, including 
the procedures used for diagnosis and treatment, the use 
of resources, and the resulting outcome and quality of 
life for the patients and it is a continuous cycle, involving 
observing practice, setting standards, comparing practice 
with standards, implementing changes and observing 
new practice 4. Thus medical audit is a systematic 
approach to peer review of medical care in order to 
identify opportunities for improvements and provide a 
mechanism for realizing them5.  Prescription audit is a 
part of medical audit 6.   
Quality of medical care rendered can only be assessed by 
prescription audit, because it is based on documented 
evidence to support diagnosis, treatment and justified 
utilization of hospital facilities. In principle, it is an 
objective and systemic way of evaluating quality of 
treatment and care provided by the physicians 7. 
Prescription audit is a tool designed for a particular 
purpose that is the objective documentation by and to the 
doctors of how far their care conforms to their own 
standards. Hence prescription audit is a tool as well as a 
technique and its application is science as well as an art 8. 
The study of prescribing patterns seeks to monitor, 
evaluate and if necessary suggest modifications in 
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prescribing practices of medical practitioners to make 
medical care rational and cost effective9. Auditing 
prescriptions also forms part of drug utilization studies, 
that auditing prescribing indicators but drug utilization 
study also includes patients care indicators like average 
consultation time, average dispensing time, % of drugs 
actually dispensed, % of drugs adequately labeled, 
patients’ knowledge of correct dosage and facility 
indicators like availability of copy of essential drugs list 
or formulary, availability of key drugs10.  
Prescription auditing has the enormous potential to 
promote the rational usages of drugs and essential 
medicine. Essential medicines are one of the vital tools 
needed to improve and maintain health. However, for too 
many people throughout the world medicines are still 
unaffordable, unavailable, unsafe and improperly used. 
An estimated one-third of the world’s population lack 
regular access to essential drugs, with this figure rising to 
over 50% in the poorest parts of Africa and Asia. When 
available, the medicines are often used incorrectly: 
around 50% of all medicines are prescribed, dispensed or 
sold inappropriately, while 50% of patients fail to take 
their medicines appropriately11.  
Since the beginning of the 1980s the essential drugs 
concept has become one of the cornerstones of 
international and national health policy – influencing 
decision making in not only developing but also 
industrialized countries. The selection and rational use of 
medicines are accepted as key principles of health 
service quality and management in both the public and 
private sectors. WHO has vigorously promoted the 
rational use of drugs through the Action Programme on 
Essential Drugs12.  According to WHO, definition of 
rational use of drugs is, “Patients receive medications 
appropriate to their clinical needs, in doses that meet 
their own individual requirements, for an adequate 
period of time, and at the lowest cost to them and their 
community”13, and it is the National list of Essential 
Medicines which can promote the rational use of drugs. 
Essential medicines are those that satisfy the priority 
healthcare needs of majority of the population. The 
essential medicines list needs to be country specific 
addressing the disease burden of the nation and the 
commonly used medicines at primary, secondary and 
tertiary healthcare levels. The medicines in National List 
of Essential Medicines (NLEM) should be available at 
affordable costs and with assured quality. The medicines 
used in the various national health programmes, 
emerging and reemerging infections should be addressed 
in the list. The Government of India, Ministry of Health 
& Family Welfare (MOHFW) is mandated to ensure the 
quality healthcare system by assuring availability of safe 
and efficacious medicines for its population14.The 
primary purpose of NLEM is to promote rational use of 
medicines considering the three important aspects i.e. 
cost, safety and efficacy. Furthermore it promotes 
prescription by generic names. The National list of 
essential medicines is one of the key instruments in 
balanced healthcare delivery system of a country which 
inter alia includes accessible, affordable quality medicine 
at all the primary, secondary, tertiary levels of 
healthcare. Realizing this GOI, MOHFW decided to have 
its own essential medicines list. The first National List of 
Essential Medicines of India was prepared and released 
in 1996. This list was subsequently revised in 2003. In 
India total Medicines are 348 according to NLEM 2011, 
out of that at the Tertiary care level (Category T) is 61, at 
the level of both Tertiary & Secondary care (Category 
ST) -106 and at the level of Primary, Secondary & 
Tertiary care14 (Category PST) -181. 
Medicines are one of our most cost‐effective health 
interventions. Billions of people take them every year. 
However, they are only effective if used correctly and 
there is evidence suggesting that more than half of all 
medicines are not used in an appropriate way. Such 
inappropriate use endangers lives and wastes money. 
Inappropriate use of prescription medicines is a global 
problem with serious consequences for patients in terms 
of poor health outcomes, increased adverse drug events, 
accelerating rates of antimicrobial resistance, spread of 
blood‐borne infections due to non‐sterile injections, and 
waste of scarce health resources. Many of these sources 
of wastage could be reduced only by prescription 
auditing15.   
Different studies conducted on the prescription 
auditing16-19 in different parts of the World produced 
their own database for the future comparative study. In 
this perspective the present study was conducted in this 
part of the World at the Burdwan Medical College& 
Hospital, West Bengal, India to create our own database 
for future comparative study on the impact of auditing, 
with the following objectives. (1)  Socio-demographic 
characteristic of the patients with the current morbidity 
pattern in this tertiary care teaching hospital of Eastern 
India. (2) OPD contributing the maximum number of 
patients. (3) Prevalence pattern of prescribing major drug 
groups at our institution. (4)   Assessment of Rational 
Prescription pattern in this Tertiary Care Teaching 
Hospital in Eastern India by measuring the WHO Core 
Prescribing Indicators. (5) To quantifying and describing 
the appropriateness of medical care by analysis of Errors 
of the Mechanics of Prescription Order Writing. 
MATERIALS AND METHODS: 
Study Place: Out Patients Department of Burdwan 
Medical College & Hospital, West Bengal 
Duration of the Study: From 1st May 2012 to 31st 
August 2013. 
Design of the Study:  Prospective observational cross 
sectional study. 
Ethical Consideration: Prior to conduct, the study was 
approved by the Institutional Ethical Committee in the 
Dec’2011, but this study had been started late due to 
some technical reasons. 
Data Collection and methodology: The study was 
carried out prospectively over a period of sixteen months 
in General medicine, Surgery, Gynecology& Obstetrics’, 
Pediatrics, Orthopedics, Skin, ENT, Eye, Psychiatry 
OPD of our tertiary care teaching hospital. A specially 
designed pro-forma was used with pre-inserted carbons 
which were quite similar to the OPD cards. The forms 
were given only to the new cases, as the study was aimed 
at First Encounter Prescription. Before the start of the 
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study all the doctors were explained the objectives of the 
study and method of using the specially designed pro-
forma. The doctors retained the carbon copy of all the 
prescriptions which were collected from time to time. 
Out of the 4500 filled-up pro-forma collected, only 4180 
were analyzed. Diagnoses in the filled-up pro-forma 
were coded using International Statistical Classification 
of Diseases & Health Related Disorders-10 (ICD-10)20 
and the drugs were coded using the Anatomical 
Therapeutic and Chemical Classification (ATC)21 
adopted by the World Health Organization.  
Parameters: Details of each prescription was analyzed 
as per as the following parameters   
A. Demographic Characteristics of the patients 
involved. 
B. Morbidity Pattern of the Prescription. 
C. Prevalence pattern of prescribing major drug 
groups.   
D. The Mechanics of Prescription Order Writing
22
: 
The prescription consists of the superscription, the 
inscription, the subscription, the signa, and the name and 
signature of the prescriber, all contained on a single 
form. 
(a) Superscription: The superscription includes the 
date the prescription order is written; the name, 
address, weight, and age of the patient; and the Rx. 
The symbol "Rx" is said to be an abbreviation for 
the Latin word recipe, meaning "take" or "take thus," 
as a direction or order to a pharmacist, preceding the 
physician's "recipe" for preparing a medication. 
Purpose: The patient's name and address are needed 
on the prescription order to ensure that the correct 
medication goes to the proper patient and also for 
identification and recordkeeping purposes. For 
medications whose dosage involves a calculation, a 
patient's pertinent factors, such as weight, age, or 
body surface area, also should be listed on the 
prescription. Prescribers should view this effort as 
one that serves their goal of protecting their patient 
from errors rather than a burden (safety first). 
(b) Inscription: The body of the prescription. It 
contains the name and amount or strength of the 
drug to be dispensed, or the name and strength of 
each ingredient to be compounded. The point noted 
as (i) Appropriateness of the prescribed drug 
according to the clinical condition -
inappropriateness or not. (ii) Legibility of writing 
the prescription. Poor handwriting is a well-known 
and preventable cause of dispensing errors. 
Accuracy and legibility are essential. (iii) Avoiding 
confusion of term e.g. μg. for microgram, mg. for 
milligram, tablespoonful, teaspoonful. 
(iv)Abbreviation of medicine. (v) Usage of Arabic 
(decimal) numerals rather than Roman numerals 
(e.g., does "IL-II" mean "IL-11" or "IL-2"?); in 
some instances, it is preferable for numerals to be 
spelled out. Others parameters among the inscription 
noted in WHO core prescribing indicators23 as 
mentioned below.  
(c) Subscription: The subscription is the instruction to 
the pharmacist, usually consisting of a short 
sentence such as: "make a solution," "mix and place 
into 30 capsules," or "dispense 30 tablets."  
(d) Signa: The signa or "Sig" is the instruction for the 
patient as to how to take the prescription, interpreted 
and transposed onto the prescription label by the 
pharmacist. The abbreviation "Sig" for the Latin 
Signatura, is used on the prescription to mark the 
directions for administration of the medication. Use 
of abbreviations in direction, particularly Latin, is 
discouraged, because it leads to dispensing errors, 
also “take as directed” like direction. 
(e) Signature: Prescriber identity, name, address and 
qualification. It requires that prescriptions for 
controlled substances include the name, address, and 
registration number of the physician. 
B. WHO core prescribing indicators
23
: The indicators 
of prescribing practices measure the performance of 
health care providers in several key dimensions related to 
the appropriate use of drugs. The indicators are based on 
the practices observed in a sample of clinical encounters 
taking place at outpatient health facilities for the 
treatment of acute or chronic illness. These encounters 
can be observed from a group of patients attending the 
clinic on the day the data collected. The core prescribing 
indicators do not require the collection of any 
information on signs and symptoms. Because the 
samples of clinical encounters cover a broad spectrum of 
health problems, the core prescribing indicators measure 
general prescribing tendencies within a given setting, 
independent of specific diagnoses.  
(1) Average number of drugs per prescription:    
a) Purpose: To measure the degree of poly-pharmacy b) 
Prerequisite: Combination drugs are counted as one. c) 
Calculation: Average, calculated by dividing the total 
number of different drug products prescribed, by the 
number of encounters (meaning prescription) surveyed. 
It is not relevant whether the patient actually received the 
drugs.  
(2) Percentage of drugs prescribed by generic name:  
a) Purpose: To measure the tendency to prescribe by 
generic name. b) Prerequisite: One must be able to 
observe the actual names used in the prescription c) 
Percentage, calculated by dividing the number of drugs 
prescribed by generic name by the total number of drugs 
prescribed, multiplied by 100.   
(3) Percentage of prescriptions with an antibiotic 
prescribed  
(4) Percentage of prescription with an injection 
prescribed  
a) Purpose: To measure the overall level of use of two 
important, but commonly overused and costly forms of 
drug therapy. b) Prerequisite: a list must be available of 
all the drug products which are to be counted as 
antibiotics; and immunization are not to be counted as 
injections. c) Calculation: Percentage, calculated by 
dividing the number of patients encounters during which 
an antibiotic or an injection are prescribed, by the total 
number of encounters surveyed, multiplied by 100. 
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(5) Percentage of drugs prescribed from essential 
drug list. 
a) Purpose: To measure the degree to which practices 
conform to a national drug policy, as indicated by 
prescribing from the national essential drugs list or the 
formulary for the type of facility surveyed. b) Copies of a 
published national essential drugs list to which data on 
prescribed drugs can be compared; procedures are 
needed for determining whether or not brand name 
products are equivalent to ones appearing in generic 
form on the drug list or formulary c) Calculation: 
Percentage, calculated by dividing the number of 
products prescribed which are listed on the essential 
drugs list by the total number of products prescribed, 
multiplied by 100. 
C. Legibility and or clarity of prescriptions.   
Statistical Analysis: Microsoft Excel was used for data 
analysis.  
Exclusion Criteria: Prescriptions of the admissible 
patients were excluded. 
RESULTS AND ANALYSIS 
In this study total 4500 prescriptions collected during the 
study period. Out of that only 4180 prescriptions 
analyzed. Proportions of male patients were higher 
(54.80%) than female while children constituted 25.11% 
and the patients aged between 12 years to 75 years 
constituted 72.70%. But age was not mentioned in 2.17% 
of patients, while in 2.03% of patients sex was not 
written. The demographic profiles of patients are shown 
in the table number 1. 
 
Table 1: Showing the socio demographic profile of the patients (n= 4180). 
                      
Characteristic  
Number of patients    % 
(n=4180) 
Age, below 12 years 1050 25.11% 
Age, 12- 60 years 1850 44.25% 
Age , 61- 75 years 1189 28.44% 
Mean Age  41.19 ± 13.18 years   
Nationality:   Indian 4180 100% 
Gender: Male  2291 54.80% 
            : Female 1804 43.15% 
Marital Status: Married  2431 58.15% 
                       : Unmarried  1749 41.84% 
Religion: Hindu 1678 40.14% 
             : Muslim 2502 59.85% 
Educational Status :Below the Secondary Education  1312 31.38% 
At the level of Secondary Education  1443 34.52% 
At the level of Higher Secondary Education  1113 26.62% 
At the level of University Education 312 7.46% 
Occupation: Unemployed 2879 68.87% 
                    : Employed 1301 31.12% 
Family Income: < Rs. 5000 per month 3116 74.54% 
                         : > Rs. 5000 per month 1064 25.45% 
 
Majority of the patients were unemployed and not at the level of higher secondary education. Majority of the patients 
(45.38%) found from the General Medicine Out Patient Department (OPD), followed by Pediatrics, Surgery and 
Gynecology & Obstetrics.  
Table 2: Showing the Contribution of Prescription by Different OPD 
 
Name of the OPD  No. of Prescription         %    (n=4180) 
General Medicine 1897 45.3827751196172% 
Surgery 550 13.1578947368421% 
Gynecology & Obstetrics 291 6.9617224880383% 
Pediatrics 1259 30.1196172248804% 
Orthopedics 490 11.7224880382775% 
Dermatology 131 3.13397129186603% 
ENT 181 4.33014354066986% 
Eye 271 6.48325358851675% 
Psychiatry 110 2.63157894736842% 
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Morbidity Pattern of the Prescriptions: Out of the 
total 4180 prescriptions 77.91% contains single diagnosis 
while 11% contain two diagnoses, 8% containing three 
diagnosis and remaining 3.79% contains no diagnosis, 
treatment based on only symptom and signs.  
The details of the morbidity pattern are shown on the 
Table no. 3 with ICD 10 Code.  
The following are the most frequent diagnosis.  
 Disease of the Digestive System ICD 10 code K00-
K99 – 12.33%  
 Infectious and Parasitic Diseases  ICD 10 code A00-
B99  --11.39%  
 Diseases of the Circulatory System ICD 10 code 
I00-I99 –10.99%  
 Diseases of the Respiratory System ICD 10 code 
J00-J99- 10.93% 
In the 19% of prescription contain more than single 
diagnosis, so the total number of morbidity pattern 
(4791) exceed the total number of prescription (4180). In 
this study it was observed that total numbers of drugs 
prescribed were 18559 and is shown with ATC Code in 
Table 3. 
 
Table 3: showing the details Morbidity Pattern: 
S.N.  
Morbidity Pattern  
ICD 10 Code No. of 
Prescription 
% 
1. Diseases of the Digestive System K00-K99    591 12.33% 
2. Diseases of the Respiratory System J00-J99    524 10.93% 
3. Infectious and Parasitic Diseases   A00-B99    546 11.39% 
4. Diseases of the Circulatory System I00-I99    527 10.99% 
5. Diseases of Blood and Blood forming Organs D50-D89    250 5.21% 
6. Diseases of the Nervous System G00-G99    209 4.36% 
7. Diseases of the Skin & Subcutaneous tissue  L00-L99    130 2.71% 
8.  Diseases of the Musculoskeletal System & Connective tissue M00-M99    162 3.38% 
9. Injury, Poisoning and certain other consequences of 
external causes. 
S00-T98    132 2.75% 
10. Neoplasm C00-D48    140 2.92% 
11. Pregnancy, Child birth and the Puerperium O00-O99    361 7.53% 
12. Congenital malformation, Deformities & chromosomal 
abnormality 
Q00-Q99    89 1.85% 
13. Diseases of Ear& Mastoid region H60-H95    283 5.90% 
14. Diseases of the Genitourinary System N00-N99    211 4.40% 
15. Diseases of the Eye and adnexa H00-H59    258 5.38% 
16. Symptom not Classified R00-R99    182 3.79% 
17.  The Mental and Behavioral disorders F01-F99    196 4.09% 
Total    4791 100% 
The prevalence patterns of major drug groups observed in this study for the treatment of the above morbidities are 
shown in Table No. 4. 
Table 4: showing the prevalence pattern of prescribing Major Drug Groups 
No.     Drug Groups No.  of Prescription % (n=4180) 
1 Anti-infective drugs/Antibiotic/Antimicrobials 1208 28.899% 
2 Gastrointestinal system drugs. 526 12.583% 
3 Respiratory system agents. 380 9.090% 
4 Cardiovascular system drugs. 415 9.928% 
5 Musculoskeletal system agents. 180 4.306% 
6 Central nervous system drugs. 205 4.904% 
7 Minerals and vitamins. 488 11.674% 
8 Ear, nose and throat preparations. 210 5.023% 
9 Skin preparations. 90 2.153% 
10 Endocrine system agents. 91 2.177% 
11 Eye preparations. 206 4.928% 
12 Anticancer drugs. 181 4.330% 
                                  Total Number of Prescriptions- 4180 100% 
 
The most prescribed category of drugs was anti-
infective/antibiotic/antimicrobials, followed by drugs of 
the gastrointestinal system, minerals& vitamins 
cardiovascular system drugs, drugs of the respiratory 
system, ear, nose and throat preparation, eye preparation, 
drugs of the central nervous system, anti cancer drugs in 
decreasing frequency order. In this study it was observed 
that only 17.77% of total prescriptions contained single 
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drugs as mono-therapy and rest of the prescriptions 
contained poly-therapy with maximum portion of the 
prescriptions (30.09%) contained four drugs. Frequency 
of drug administrations per prescription is shown in 
Table no.5. 
 
Table 5: showing the frequency drug administration per prescription 
 
       No. of drugs per prescription 
No. of prescriptions        % 
(n=4180) 
    0 89 2.129% 
    1 718 17.177% 
    2 811 19.401% 
    3 1012 24.210% 
    4 1258 30.095% 
    Above 4 292 6.985% 
               Total number of prescription - 4180 100% 
Table 6: Showing the numbers of antibiotics prescribed per encounter/ patient 
Parameter No. of patients.( Total n=4180)      % 
Antibiotic prescriptions. 1208 28.899% 
Single antibiotic. 201 4.808% 
Two antibiotics. 389 9.306% 
>Two antibiotics 370 8.851% 
Antimicrobial FDCs. 248 5.933% 
Table 7: Showing the distributions of Common categories of Drugs with ATC code 
Drug Group Subgroup ATC code Number % 
Quinolones (J01M). Fluoroquinolones. J01MA. 1445 7.785% 
Penicillins (J01C). Extended spectrum penicillins 
Combination of penicillins 
J01CA 
J01CR. 
270 
531 
1.454% 
2.861% 
Other β-lactams (J01D). 1st Generation 
3rd Generation 
J01DB 
J01DD. 
1011 
427 
5.447% 
2.300% 
Sulfonamide with Trimethoprim 
(J01E). 
Combination of Sulfonamide with 
Trimethoprim. 
J01EE. 274 1.476% 
Macrolides (J01F). Macrolide. J01FA. 589 3.173% 
Combination of antibiotics (J01R. Combination of antibiotics. J01RA. 1081 5.824% 
Other antibiotics (J01X). Glycopeptide antibacterials 
Imidazole derivatives. 
J01XA 
J01XD. 
02 
49 
0.01% 
0.264% 
Agents against amoebiasis and other 
protozoal diseases (P01A) 
Nitroimidazole derivatives 
Other agents against  
P01AB 
P01AX. 
231 
43 
1.244% 
0.231% 
Antiinflammatory&anti rheumatic 
products(M01A) 
Coxibs 
Propionic acid derivatives 
Oxicams 
M01AH 
M01AE 
M01AC 
789 
338 
382 
4.251% 
1.821% 
2.058% 
Analgesics(N02B) Combinations of ibuprofen and 
paracetamol. 
N02BE51 1178 6.347% 
 Drugs for acid related disorder(A02) H2-receptor antagonists 
Antacid 
Proton pump inhibitors 
A02BA 
A02A 
A02BC 
790 
364 
1189 
4.256% 
1.961% 
6.406% 
Beta blocking agents(C07A) Beta blocking agents, selective C07AB 742 3.998% 
Calcium channel blockers(C08C) Dihydropyridine derivatives C08CA 782 4.213% 
ACE inhibitors(C09) ACE inhibitors and diuretics C09BA 991 5.339% 
Angiotensin II antagonists(C09D)  Angiotensin II antagonists and 
diuretics 
C09DA 886 4.773% 
Vitamins(A11A) Multivitamins and iron A11AA01  1012 5.452% 
Cough&Cold preparation( R05) Mucolytics 
Expectorants 
R05CB 
R05CA 
645 
793 
3.475% 
4.272% 
Antihistamines for systemic use(R06A) Combinations of antihistamines R06AK 887 4.779% 
                           OTHERS 838 4.515% 
 Total 
Prescribed 
Drugs 
18559  100% 
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In the study period among the total 4180 prescriptions, 
1208 prescriptions contained antibacterial agents. Out of 
that, majority contained two antibacterial agents and only 
201 prescriptions contained single one. And 5.933% of 
the total prescriptions contained antibacterial fixed dose 
combination (FDCs). Number of antibacterial agents 
prescribed per encounter is shown in the Table no.6. 
Anti‐protozoal agents and antimicrobials primarily used 
to treat tuberculosis or malaria are excluded24. 
Among the antibacterial agents the most common 
category was fluoroquinolones, followed by combination 
of antibiotics, 1st generation cephalosporin, combination 
of penicillin, 3rd generation cephalosporin, macrolides in 
descending order. Distributions of common category of 
drugs with ATC Code are shown in the Table No.7. 
Among the analgesic-anti-inflammatory drugs most 
common category was combination of ibuprofen & 
paracetamol. Out of the gastro-intestinal drugs proton-
pump inhibitors were the most common. Among the 
drugs of the cardiovascular system the most common 
category was ACE- inhibitors with diuretics. During the 
analysis of Errors of the Mechanics of Prescription Order 
Writing, it is observed that in 91.33% of prescription 
weight is not written, while in-appropriate drugs 
prescribed in 52.99% of prescription. In-appropriate 
instruction to the pharmacist and also to the patients was 
written in 30.09% and in 56.10% of total prescription 
respectively. Follow-up advice not mentioned in 
maximum no. of prescription (97.87%).  Details results 
of analysis of error of the Mechanics of Prescription 
Order Writing are shown in the Table No.8. 
 
Table 8: showing analysis of Errors of the Mechanics of Prescription Order Writing 
Parameters Errors in particular item Numbers of 
prescription 
% out of total 4180 
prescriptions 
Superscription  Name not written 125 2.990% 
Sex not mentioned 85 2.033% 
Age not written 91 2.177% 
Weight not written 3818 91.339% 
Symbol-Rx not written 529 12.655% 
Inscription  In appropriateness 2215 52.990% 
Using of confusion term 542 12.966% 
Abbreviation of medicine  3989 95.430% 
Subscription  Error in the Instruction to the 
pharmacist 
1258 30.095% 
 
Signa  Error in the instruction to the patient 2345 56.100% 
Follow up advice not mentioned 4091 97.870% 
Use of Latin abbreviation 3998 95.645% 
Signature  Doctors Signature absent  268 6.411% 
Date not mentioned 152 3.636% 
 
Analysis of WHO core prescribing indicators
24
:  
(1) Average number of drugs per encounter (C): 
First number of encounters were counted for which 
data were collected, even if no drugs were given 
(A=4180). Then total numbers of drugs prescribed 
were added during these encounters (B=18559). 
Result was expressed by dividing the total numbers 
of drugs by the number of encounters. 
Formula: Average number of drugs prescribed: [C = 
B/A] = 18559/4180= 4.439= 4.4 
(2) Percentage of drugs prescribed by generic name 
(E): Result was calculated by dividing the total 
number of generic drugs prescribed (D=3897) by the 
total number of drugs prescribed (B), and multiplied 
by 100 to make a percentage (E). 
Formula: % Prescribed as generic: [E = (D/B) × 100%] 
= 3897/18559×100= 20.997%  
(3) Percentage of encounters with an antibiotic 
prescribed (G): It was calculated by dividing the 
total number of patients who received one or more 
antibiotics (F=1208) by the total number of 
encounters (A) and multiplied by 100 to make a 
percentage. 
Formula: % Antibiotics prescribed:  [G = (F/A) × 
100%] = 1208/4180×100 =   28.899%   
(4)   Percentage of encounters with an injection 
prescribed (I):   It was calculated by dividing the 
total number of patients who received one or more 
injections (H=1212) by the total number of 
encounters (A) and multiplied by 100 to make a 
percentage.  
Formula: % Injections prescribed:  [I = (H/A) × 100%] 
= 1212/4180 × 100 = 28.995% 
(5)  Percentage of drugs prescribed from essential 
drugs list or formulary (K): Result was calculated 
by dividing the total number of Essential Drugs 
prescribed (J=11319) by the total number of drugs 
prescribed (B) and multiplied by 100 to make a 
percentage (K). 
Formula: % Drugs prescribed from Essential Drugs 
List: [K = (J/B) × 100%]= 11319/18559×100= 60.989%      
Illegibility of Prescription(Y) was analyzed by counting 
the total number of illegible prescription (Z=961) having 
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very poor hand writing, divided by the total number of 
prescription (A), and multiplied by 100 to make a 
percentage [ Y =Z/A]=  961/4180×100=22.990% . 
 
DISCUSSION 
The evaluation of costs is known as financial audit while 
the assessment of quality of medical care is called 
medical audit25.It is the critical assessment of medical 
and healthcare related system with a view to bring about 
necessary improvement in the same. Prescription audit is 
a part of Medical audit and is seen as one approach to 
improving the quality of patient care26.  Prescription 
audit is the process of reviewing the delivery of medical 
care to identify deficiencies so that they may be 
remedied27.Benefits to patient care and service delivery 
have been commonly identified in different audit studies 
in different parts of the world28.Several studies have also 
reported that clinicians have felt they had benefited from 
audit through improvements in communication between 
professional groups and increased professional 
satisfaction and knowledge29-32.Changes in prescribing 
behavior were attributed to the fact that doctors were 
able to control the audit process using their own values 
and attitudes and that being able to compare one’s own 
practice with that of immediate colleagues and outside 
authorities provided a powerful impetus to changing 
behavior. In addition, audit was seen to promote 
communication between partners and as a stimulus to 
learn from colleagues’ behavior33.The outcome of the 
prescription auditing is to improve the patients’ care and 
rationalization of medicine prescription. Irrational or 
non-rational use is the use of medicines in a way that is 
not compliant with rational use. Worldwide more than 
50% of all medicines are prescribed, dispensed, or sold 
inappropriately, while 50% of patients fail to take them 
correctly11. Moreover, about one-third of the world’s 
population lacks access to essential medicines15. 
Common types of irrational medicine use are:(1) the use 
of too many medicines per patient (poly-pharmacy); (2) 
inappropriate use of antimicrobials, often in inadequate 
dosage, for non-bacterial infections; (3)over-use of 
injections when oral formulations would be more 
appropriate; (4) failure to prescribe in accordance with 
clinical guidelines; inappropriate self-medication, often 
of prescription only medicines13. 
Lack of access to medicines and inappropriate doses 
result in serious morbidity and mortality, particularly for 
childhood infections and chronic diseases, such as 
hypertension, diabetes, epilepsy and mental disorders. 
Inappropriate use and over-use of medicines waste 
resources – often out-of-pocket payments by patients – 
and result in significant patient harm in terms of poor 
patient outcomes and adverse drug reactions. 
Furthermore, over-use of antimicrobials is leading to 
increased antimicrobial resistance and non-sterile 
injections to the transmission of hepatitis, HIV/AIDS and 
other blood-borne diseases. Irrational over-use of 
medicines can stimulate inappropriate patient demand, 
and lead to reduced access and attendance rates due to 
medicine stock-outs and loss of patient confidence in the 
health system15.  
To address irrational use of medicines, prescribing, 
dispensing and patient use should be regularly monitored 
in terms of: (i) the types of irrational use, so that 
strategies can be targeted towards changing specific 
problems; (ii) the amount of irrational use, so that the 
size of the problem is known and the impact of the 
strategies can be monitored; (iii) the reasons why 
medicines are used irrationally, so that appropriate, 
effective and feasible strategies can be chosen. Doctors 
often have very rational reasons for using medicines 
irrationally. Causes of irrational use include lack of 
knowledge, skills or independent information, 
unrestricted availability of medicines, overwork of health 
personnel, inappropriate promotion of medicines and 
profit motives from selling medicines. There are several 
well-established methods to measure the type and degree 
of irrational use. Analysis of Errors of the Mechanics of 
Prescription Order Writing and WHO core prescribing 
indicators are such tool assessing the irrational use of 
medicine15. & indicators explore the quality of patient 
care and of health‐care facilities as they relate to 
medicines use. The data collected can then be used to 
design appropriate interventions and to measure the 
impact of those interventions on medicine use.  
In this study out of the total 4180 prescriptions, 11% 
contain two diagnosis and 8% contain three diagnoses 
while 19.40%, 24.21% & 30.09% of the total 
prescriptions contain 2, 3 &4drugs respectively 
indicating a definitive practice of poly-pharmacy. This 
may increase chances of adverse drug reactions and 
interactions.  
 From our study, 91.339%% of the prescriptions did not 
show the weight of the patients. Consequently, 
determination of dose accuracy was not possible. 
Follow-up visit not mentioned in 97.87% of total 
prescriptions and 56.1% of the prescription contain error 
in the instruction to the patient. All these anomalies 
encountered in the collected data indicate that there is a 
huge scope for improvements in the prescriptions 
patterns in our institution. Prevalence of morbidity & 
prescription data may help the health administers to take 
interventions to check and scope of further study to see 
any impact. Because the essence of the audit process is 
that it should be a continual cycle of improvement. It 
encourages the health care provider to rectify.  
In this study total number of drugs from 4180 
prescription was 18559 and average number of 
prescribed drugs was 4.4. In different studies in different 
countries this average number ranges from 1.3 to 2.2. 
And according to Yemen study34, ideally it should be 1.4. 
In previous study in India35 it was 3. So in our institution 
there is a trend of poly-pharmacy indicating irrational 
prescription. The figure for percentage of drugs 
prescribed by generic names is discouraging Percentage 
of 20.99%, as in other Indian studies35 it was 59%. 
Levels as high as 82% to 94% offers ideal rationalization 
of prescription & improve wastage of scarce health 
resources34. Because of rising cost of healthcare has 
favored the dispensing of so-called "generic" drugs. Also 
generic prescribing reduces the chances of dispensing 
errors which may be due to misinterpretation of like 
sounding brand names of drugs.  Percentage of 
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encounters with an antibiotic prescribed was 28.89%. In 
different countries this is36 between29% to 43% and 
according to Yemen study34 suggested a theoretical need 
of 22.7% which is fur less than our study, indicating 
inappropriate antibiotic prescription. But earlier studies 
in India it was 43%. What is striking about injectables is 
the considerable variation between countries from 0.2% 
to 48%. In India35 cumulative result was 17%.  For 
Yemen34 the ideal figure is 17.2%.But in this study 
percentage of encounters with an injection prescribed 
was 28.995%, indicating again inappropriate prescription 
of injection. Percentage of drugs prescribed from 
essential drugs list or formulary was 60.989%, where as 
in Nepal this figure is 86%37. 
This study reveals that the auditing of prescription in 
terms of rationality, it remains poor. WHO recently has 
taken twelve core interventions to promote more rational 
use of medicines15.  
 A mandated multi-disciplinary national body to 
coordinate medicine use policies 
 Clinical guidelines i.e. Standard Treatment 
Guidelines 
 Essential medicines list based on treatments of 
choice 
 Drugs and therapeutics committees in hospitals 
 Problem-based pharmacotherapy training in 
undergraduate curricula 
 Continuing in-service medical education as a 
licensure requirement 
 Supervision, audit and feedback 
 Independent information on medicines 
 Public education about medicines 
 Avoidance of perverse financial incentives 
 Appropriate and enforced regulation 
 Sufficient government expenditure to ensure 
availability of medicines and staff. 
The doctors should know that the drugs provided by the 
Hospital are of good quality. They could be obtained at a 
lower cost even from the hospital fair price shop because 
of procurement practices like (1) buying directly from 
the manufacturer, (2) centralized procurement practices 
(3) and buying at the generic name instead of brands 
name. This important because some doctors believe that 
these drugs are of poor & inferior quality. So they 
prescribe well-known brands. Doctors should be made 
aware of the advantages of prescribing drugs using 
generic names, such as (1) cost effectiveness (2) and 
minimizing medication error due to branded brand 
names. Lastly more stringent measures like those 
initiated by the Government of Orissa38 such as, recovery 
of the cost of drugs if the prescription is found 
unjustified, could be considered by the State 
Government.  
CONCLUSION  
The information gathered from this study should be a 
pointer to the trends in prescribing patterns. The present 
study could serve as a frame work upon which further 
studies in prescription audit can be launched to 
investigate the scope for educational intervention and 
improvement in prescribing patterns. Prescription audit is 
an important tool to improve the quality patients’ care. 
Data created on the morbidity pattern coupled with 
present practice of prescription will help in the 
generation of action plan also in order to improve the 
quality of care, and recommendations for changing the 
present prescribing practices. Comparing the current 
usage of drugs with the standard treatment guidelines 
will enhance the effectiveness of treatment and render it 
most cost effective.  
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